Literature DB >> 25056799

Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.

T Porcelli1, D Gotti, A Cristiano, F Maffezzoni, G Mazziotti, E Focà, F Castelli, A Giustina, E Quiros-Roldan.   

Abstract

UNLABELLED: This study investigated the bone of HIV patients both in terms of quantity and quality. It was found that HIV-infected patients did fracture independently of the degree of bone demineralization as in other forms of secondary osteoporosis.
INTRODUCTION: We aimed to determine the prevalence of vertebral fractures (VFs) in HIV patients who were screened by bone mineral density (BMD) and to explore possible factors associated with VFs.
METHODS: This is a cross-sectional study that included HIV-infected patients recruited in the Clinic of Infectious and Tropical Diseases and that underwent BMD measurement by dual-energy X-ray absorptiometry (DXA) at the lumbar spine and hip (Lunar Prodigy, GE Healthcare). For the assessment of VFs, anteroposterior and lateral X-ray examinations of the thoracic and lumbar spines were performed and were centrally digitized. Logistic regression models were used in the statistical analysis of factors associated with VFs.
RESULTS: One hundred thirty-one consecutive patients with HIV infection (93 M, 38 F, median age 51 years; range, 36-75) underwent BMD measurement: 25.2 % of patients showed normal BMD, while 45 % were osteopenic and 29.7 % osteoporotic. Prevalence of low BMD (osteopenia and osteoporosis) was higher in females as compared to males (90 vs 69 %) with no significant correlation with age and body mass index. VFs occurred more frequently in patients with low BMD as compared to patients with normal BMD (88.5 vs. 11.4 %; p < 0.001) without any significant difference between osteopenia and osteoporosis (43 vs. 46 %; p = 0.073). VFs were significantly associated with older age and previous AIDS events.
CONCLUSIONS: These results suggest a BMD <-1 threshold to identify patients at risk of skeletal fragility and, therefore, good candidates for morphometric evaluation of spine X-ray in line with other forms of secondary osteoporosis with impaired bone quality.

Entities:  

Mesh:

Year:  2014        PMID: 25056799     DOI: 10.1007/s00198-014-2760-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  44 in total

1.  Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

Authors:  H Knobel; A Guelar; G Vallecillo; X Nogués; A Díez
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

Review 2.  Drug-induced osteoporosis: mechanisms and clinical implications.

Authors:  Gherardo Mazziotti; Ernesto Canalis; Andrea Giustina
Journal:  Am J Med       Date:  2010-10       Impact factor: 4.965

3.  Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.

Authors:  Claudine Duvivier; Sami Kolta; Lambert Assoumou; Jade Ghosn; Sylvie Rozenberg; Robert L Murphy; Christine Katlama; Dominique Costagliola
Journal:  AIDS       Date:  2009-04-27       Impact factor: 4.177

Review 4.  New advances in imaging osteoporosis and its complications.

Authors:  James F Griffith; Harry K Genant
Journal:  Endocrine       Date:  2012-05-23       Impact factor: 3.633

Review 5.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

6.  High prevalence of radiological vertebral fractures in HIV-infected males.

Authors:  Carlo Torti; Gherardo Mazziotti; Pier Antonio Soldini; Emanuele Focà; Roberto Maroldi; Daria Gotti; Giampiero Carosi; Andrea Giustina
Journal:  Endocrine       Date:  2011-12-25       Impact factor: 3.633

7.  The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.

Authors:  Jessica Pepe; Andrea M Isidori; Mario Falciano; Giancarlo Iaiani; Alessandra Salotti; Daniele Diacinti; Romano Del Fiacco; Emilia Sbardella; Cristiana Cipriani; Sara Piemonte; Elisabetta Romagnoli; Andrea Lenzi; Salvatore Minisola
Journal:  Clin Endocrinol (Oxf)       Date:  2012-11       Impact factor: 3.478

Review 8.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

9.  Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.

Authors:  Julia H Arnsten; Ruth Freeman; Andrea A Howard; Michelle Floris-Moore; Yungtai Lo; Robert S Klein
Journal:  AIDS       Date:  2007-03-12       Impact factor: 4.177

10.  Prevalence of vertebral fractures in men with acromegaly.

Authors:  Gherardo Mazziotti; Antonio Bianchi; Stefania Bonadonna; Vincenzo Cimino; Ilaria Patelli; Alessandra Fusco; Alfredo Pontecorvi; Laura De Marinis; Andrea Giustina
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

View more
  8 in total

Review 1.  Bone health in HIV and hepatitis B or C infections.

Authors:  Emmanuel Biver; Alexandra Calmy; René Rizzoli
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-10-07       Impact factor: 5.346

2.  DUAL-ENERGY X-RAY ABSORPTIOMETRY AND CALCULATED FRAX RISK SCORES MAY UNDERESTIMATE OSTEOPOROTIC FRACTURE RISK IN VITAMIN D-DEFICIENT VETERANS WITH HIV INFECTION.

Authors:  Kelly I Stephens; Leon Rubinsztain; John Payan; Chris Rentsch; David Rimland; Vin Tangpricha
Journal:  Endocr Pract       Date:  2015-12-18       Impact factor: 3.443

3.  Trabecular bone score (TBS) is associated with sub-clinical vertebral fractures in HIV-infected patients.

Authors:  Lorenzo Ciullini; A Pennica; G Argento; D Novarini; E Teti; G Pugliese; A Aceti; F G Conti
Journal:  J Bone Miner Metab       Date:  2017-02-23       Impact factor: 2.626

4.  Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study.

Authors:  Cecilia Costa; Silvia Scabini; Arvind Kaimal; William Kasozi; Jessica Cusato; Bosco Kafufu; Marco Borderi; Erisa Mwaka; Giovanni Di Perri; Mohammed Lamorde; Andrea Calcagno; Barbara Castelnuovo
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 5.226

5.  Impact of hypogonadism on bone mineral density and vertebral fractures in HIV-infected men.

Authors:  L C Pezzaioli; T Porcelli; A Delbarba; F Maffezzoni; E Focà; F Castelli; C Cappelli; A Ferlin; M E Quiros-Roldan
Journal:  J Endocrinol Invest       Date:  2021-08-30       Impact factor: 4.256

6.  Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort.

Authors:  Eugenia Quiros Roldan; Nigritella Brianese; Elena Raffetti; Emanuele Focà; Maria Chiara Pezzoli; Andrea Bonito; Alice Ferraresi; Paola Lanza; Teresa Porcelli; Francesco Castelli
Journal:  Braz J Infect Dis       Date:  2017-09-23       Impact factor: 3.257

7.  HIV and Vertebral Fractures: a Systematic Review and Metanalysis.

Authors:  Thales A S H Ilha; Fabio V Comim; Rafaela M Copes; Juliet E Compston; Melissa O Premaor
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

8.  Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.

Authors:  Emanuele Focà; Paola Magro; Giovanni Guaraldi; Agostino Riva; Anna Maria Cattelan; Giuseppe Vittorio De Socio; Cecilia Costa; Stefania Piconi; Benedetto Maurizio Celesia; Silvia Nozza; Giancarlo Orofino; Antonella Castagna; Giovanni Di Perri; Francesco Castelli; Andrea Calcagno
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.